Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Quetiapine (CAS 111974-69-7) Market by Type (Purity 97%, Purity 98%, Other), By Application (Adult, Aged) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Quetiapine (CAS 111974-69-7) Market by Type (Purity 97%, Purity 98%, Other), By Application (Adult, Aged) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 130229 3300 Chemical & Material 377 243 Pages 4.8 (44)
                                          

Market Overview:


The global quetiapine market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of mental disorders, increasing awareness about mental health, and growing demand for quetiapine in emerging markets. However, patent expiry of key products and stringent regulatory environment are some of the major factors that are likely to restrain the growth of this market during the forecast period. On the basis of type, the global quetiapine market is segmented into purity 97%, purity 98%, and other. The purity 97% segment is expected to account for a major share of the global quetiapine market during the forecast period owing to its high demand among patients suffering from various mental disorders. On the basis of application, adult accounts for a majority share in terms of revenue generated by this market due to high prevalence rateof mental disorders among adults across different geographies.


Global Quetiapine (CAS 111974-69-7) Industry Outlook


Product Definition:


Quetiapine (CAS 111974-69-7) is a drug used to treat schizophrenia, bipolar disorder, and depression. It belongs to a class of drugs called atypical antipsychotics.


Purity 97%:


Purity 97% is a colorless and odorless liquid that has been used as an intermediate in the production of various chemicals. It is also used as a solvent for producing quetiapine, which has been approved by the U.S. FDA and European Medicines Agency (EMA) for clinical use.


Purity 98%:


Purity 98% is a colorless and highly viscous liquid with an odor similar to that of turpentine. It has a density of 0.98 g/mL and isopropyl alcohol content of 99%. Purity 98% can be used as an alternative to benzene, chloroform, ethylene glycol, acetone, methylene chloride or any other organic solvent for the extraction process.


Application Insights:


The major applications of quetiapine include the treatment of schizophrenia and bipolar disorder. The adult application segment dominated the global market in 2017, accounting for over 60% share in terms of revenue. Schizophrenia is a chronic mental illness that affects about 1.2 billion people globally, according to the World Health Organization (WHO). Treatment with antipsychotics is highly effective in reducing symptoms of schizophrenia such as hallucinations and delusions. However, adverse effects associated with these drugs are also significant concerns for patients and their families when choosing between different treatments options available for schizophrenic disorders.


The aged application segment is expected to grow at a lucrative rate during the forecast period owing to increasing geriatric population across various regions including North America, Europe, Asia Pacific.


Regional Analysis:


Asia Pacific was the largest regional market in 2017 and is expected to maintain its position during the forecast period. The presence of major manufacturers in China, along with increased demand from countries such as India, Japan, and South Korea is anticipated to drive growth. In addition, growing awareness about atypical antipsychotic drugs among patients and physicians will support market development.


The European region accounted for a significant share of revenue in 2017 owing to high prevalence of schizophrenia among the population coupled with favorable government initiatives for improving mental health care access. Moreover, increasing funding by organizations such as EU’s Horizon 2020 research & innovation program supports new drug development which will further boost growth over the forecast period. North America region is expected witness steady growth due to factors such as rising geriatric population prone to neuropsychiatric disorders coupled with growing awareness about atypical antipsychotics usage rates amongst patients suffering from schizophrenia spectrum disorders including bipolar disorder and depression etc.


Growth Factors:


  • Increasing prevalence of mental disorders: The global prevalence of mental disorders is increasing at an alarming rate. According to the World Health Organization (WHO), around 450 million people suffer from some form of mental disorder, which is nearly one-sixth of the world's population. This number is expected to increase to 615 million by 2030. Quetiapine is a highly effective treatment for various mental disorders such as schizophrenia, bipolar disorder, and major depressive disorder. Hence, the demand for quetiapine is expected to rise in the coming years.
  • Growing awareness about psychiatric medications: There has been a growing awareness about psychiatric medications in recent years due to increasing incidences of mental health problems across the globe. This has led to an increase in demand for quetiapine and other psychiatric drugs worldwide.

Scope Of The Report

Report Attributes

Report Details

Report Title

Quetiapine (CAS 111974-69-7) Market Research Report

By Type

Purity 97%, Purity 98%, Other

By Application

Adult, Aged

By Companies

BOC Sciences, EMMX Biotechnology, Toronto Research Chemicals, Waterstone Technology, AlliChem, Nanjing Chemlin Chemical, XiaoGan ShenYuan ChemPharm, Wuhan Fortuna Chemical, Shanghai Haoyuan Chemexpress, Nanjing Sunlida Biological Technology

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

243

Number of Tables & Figures

171

Customization Available

Yes, the report can be customized as per your need.


Global Quetiapine (CAS 111974-69-7) Market Report Segments:

The global Quetiapine (CAS 111974-69-7) market is segmented on the basis of:

Types

Purity 97%, Purity 98%, Other

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Adult, Aged

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. BOC Sciences
  2. EMMX Biotechnology
  3. Toronto Research Chemicals
  4. Waterstone Technology
  5. AlliChem
  6. Nanjing Chemlin Chemical
  7. XiaoGan ShenYuan ChemPharm
  8. Wuhan Fortuna Chemical
  9. Shanghai Haoyuan Chemexpress
  10. Nanjing Sunlida Biological Technology

Global Quetiapine (CAS 111974-69-7) Market Overview


Highlights of The Quetiapine (CAS 111974-69-7) Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of Alpha Hydroxy Acid for Cosmetic Market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Purity 97%
    2. Purity 98%
    3. Other
  1. By Application:

    1. Adult
    2. Aged
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Quetiapine (CAS 111974-69-7) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Quetiapine (CAS 111974-69-7) Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available
                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Quetiapine (CAS 111974-69-7) Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Quetiapine (CAS 111974-69-7) Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Quetiapine (CAS 111974-69-7) Market - Supply Chain
   4.5. Global Quetiapine (CAS 111974-69-7) Market Forecast
      4.5.1. Quetiapine (CAS 111974-69-7) Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Quetiapine (CAS 111974-69-7) Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Quetiapine (CAS 111974-69-7) Market Absolute $ Opportunity

5. Global Quetiapine (CAS 111974-69-7) Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Type
      5.3.1. Purity 97%
      5.3.2. Purity 98%
      5.3.3. Other
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Quetiapine (CAS 111974-69-7) Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Application
      6.3.1. Adult
      6.3.2. Aged
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Quetiapine (CAS 111974-69-7) Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Quetiapine (CAS 111974-69-7) Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Quetiapine (CAS 111974-69-7) Demand Share Forecast, 2019-2029

9. North America Quetiapine (CAS 111974-69-7) Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Application
      9.4.1. Adult
      9.4.2. Aged
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Type
      9.7.1. Purity 97%
      9.7.2. Purity 98%
      9.7.3. Other
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Quetiapine (CAS 111974-69-7) Demand Share Forecast, 2019-2029

10. Latin America Quetiapine (CAS 111974-69-7) Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Application
      10.4.1. Adult
      10.4.2. Aged
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Type
      10.7.1. Purity 97%
      10.7.2. Purity 98%
      10.7.3. Other
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Quetiapine (CAS 111974-69-7) Demand Share Forecast, 2019-2029

11. Europe Quetiapine (CAS 111974-69-7) Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Application
      11.4.1. Adult
      11.4.2. Aged
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Type
      11.7.1. Purity 97%
      11.7.2. Purity 98%
      11.7.3. Other
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Quetiapine (CAS 111974-69-7) Demand Share, 2019-2029

12. Asia Pacific Quetiapine (CAS 111974-69-7) Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Application
      12.4.1. Adult
      12.4.2. Aged
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Type
      12.7.1. Purity 97%
      12.7.2. Purity 98%
      12.7.3. Other
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Quetiapine (CAS 111974-69-7) Demand Share, 2019-2029

13. Middle East & Africa Quetiapine (CAS 111974-69-7) Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Application
      13.4.1. Adult
      13.4.2. Aged
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Type
      13.7.1. Purity 97%
      13.7.2. Purity 98%
      13.7.3. Other
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Quetiapine (CAS 111974-69-7) Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Quetiapine (CAS 111974-69-7) Market: Market Share Analysis
   14.2. Quetiapine (CAS 111974-69-7) Distributors and Customers
   14.3. Quetiapine (CAS 111974-69-7) Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. BOC Sciences
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. EMMX Biotechnology
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Toronto Research Chemicals
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Waterstone Technology
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. AlliChem
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Nanjing Chemlin Chemical
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. XiaoGan ShenYuan ChemPharm
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Wuhan Fortuna Chemical
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Shanghai Haoyuan Chemexpress
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Nanjing Sunlida Biological Technology
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us